Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
Search for other papers by Sule Canberk in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Joana C. Ferreira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Luísa Pereira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Rui Batısta in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Andre F. Vieira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
Department of Pathology and Oncology, Centro Hospitalar São João, Porto, Portugal
Search for other papers by Manuel Sobrinho Simões in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Valdemar Máximo in
Google Scholar
PubMed
Variant Classification The TCGA data was filtered for the detection of DICER1 germline variants by a 2-step filtering process. First, exome-aligned sequence data from non-tumour samples (mostly from the blood, and, when not available, from thyroid
Inserm U1173, Université Versailles-Saint-Quentin, Montigny-Le-Bretonneux, France
Search for other papers by Laure Cazabat in
Google Scholar
PubMed
Search for other papers by Aglae Terray in
Google Scholar
PubMed
Search for other papers by Philippe de Mazancourt in
Google Scholar
PubMed
Search for other papers by Jacques Ropers in
Google Scholar
PubMed
UMR 8104, Institut Cochin, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
Inserm U1173, Université Versailles-Saint-Quentin, Montigny-Le-Bretonneux, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
thyroid cancer risk in Hispanics. Endocr Connect 2016; 5: 123–127. 10.1530/EC-16-0017 27097599 7 Weeks AL, Wilson SG, Ward L, Goldblatt J, Hui J, Walsh JP: HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer. BMC Med Genet
Search for other papers by Elen Dias Accordi in
Google Scholar
PubMed
Search for other papers by Paraskevi Xekouki in
Google Scholar
PubMed
Search for other papers by Bruna Azevedo in
Google Scholar
PubMed
Search for other papers by Rodrigo Bertollo de Alexandre in
Google Scholar
PubMed
Álvaro Center for Analysis and Clinical Research - Diagnósticos da América (DASA), Cascavel, Brazil
Search for other papers by Carla Frasson in
Google Scholar
PubMed
Search for other papers by Siliane Marie Gantzel in
Google Scholar
PubMed
Search for other papers by Georgios Z. Papadakis in
Google Scholar
PubMed
Search for other papers by Anna Angelousi in
Google Scholar
PubMed
Search for other papers by Constantine A. Stratakis in
Google Scholar
PubMed
Search for other papers by Vanessa Santos Sotomaior in
Google Scholar
PubMed
Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics (PDEGEN) and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)
Search for other papers by Fabio R. Faucz in
Google Scholar
PubMed
with thyroid cancer. Other studies [ 14 , 24 ] have shown that germline variants of the S DHB , SDHC, or SDHD genes may occur in a subset of PTEN mutation-negative Cowden and Cowden-like syndrome individuals. These individuals presented more
Search for other papers by Julia A Baran in
Google Scholar
PubMed
Search for other papers by Mya Bojarsky in
Google Scholar
PubMed
Search for other papers by Stephen Halada in
Google Scholar
PubMed
Search for other papers by Julio C Ricarte-Filho in
Google Scholar
PubMed
Search for other papers by Amber Isaza in
Google Scholar
PubMed
Search for other papers by Aime T Franco in
Google Scholar
PubMed
Search for other papers by Lea F Surrey in
Google Scholar
PubMed
Search for other papers by Tricia Bhatti in
Google Scholar
PubMed
Search for other papers by Zubair Baloch in
Google Scholar
PubMed
Search for other papers by N Scott Adzick in
Google Scholar
PubMed
Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Search for other papers by Sogol Mostoufi-Moab in
Google Scholar
PubMed
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by Ken Kazahaya in
Google Scholar
PubMed
Search for other papers by Andrew J Bauer in
Google Scholar
PubMed
/LP oncogenic alterations (3/192, 2%), including RAD50 , CHEK2 ,or BLM , or carry germline variants (2/192, 1%). Of the 40 patients with no identifiable driver thyroid oncogenic alteration, 43% (17/40) underwent research molecular testing using the Asuragen
Search for other papers by Chantal A Lebbink in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Renuka P Dias in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Louise Izatt in
Google Scholar
PubMed
Search for other papers by Heiko Krude in
Google Scholar
PubMed
Search for other papers by Kerstin Lorenz in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Arnoldo Piccardo in
Google Scholar
PubMed
Search for other papers by Manuel Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by Toru Takano in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by Frederik A Verburg in
Google Scholar
PubMed
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Rosenberg PS Neoplasm risk among individuals with a pathogenic germline variant in DICER1 . Journal of Clinical Oncology 2019 37 668 – 676 . ( https://doi.org/10.1200/JCO.2018.78.4678 ) 138 Yamashita S Saenko V . Mechanisms of disease: molecular